QQQ   292.59 (+1.69%)
AAPL   143.49 (+1.15%)
MSFT   247.06 (+2.68%)
META   147.04 (+3.92%)
GOOGL   97.36 (+2.25%)
AMZN   98.69 (+1.55%)
TSLA   159.50 (+10.43%)
NVDA   196.70 (+1.80%)
NIO   12.13 (+4.30%)
BABA   120.61 (+0.30%)
AMD   74.66 (-0.33%)
T   19.93 (-2.40%)
MU   62.48 (+1.53%)
F   12.90 (+0.86%)
CGC   2.74 (-0.72%)
GE   81.21 (+0.52%)
DIS   109.38 (+1.17%)
AMC   5.24 (-1.69%)
PFE   44.17 (-2.00%)
PYPL   80.39 (+1.63%)
NFLX   365.01 (-0.80%)
QQQ   292.59 (+1.69%)
AAPL   143.49 (+1.15%)
MSFT   247.06 (+2.68%)
META   147.04 (+3.92%)
GOOGL   97.36 (+2.25%)
AMZN   98.69 (+1.55%)
TSLA   159.50 (+10.43%)
NVDA   196.70 (+1.80%)
NIO   12.13 (+4.30%)
BABA   120.61 (+0.30%)
AMD   74.66 (-0.33%)
T   19.93 (-2.40%)
MU   62.48 (+1.53%)
F   12.90 (+0.86%)
CGC   2.74 (-0.72%)
GE   81.21 (+0.52%)
DIS   109.38 (+1.17%)
AMC   5.24 (-1.69%)
PFE   44.17 (-2.00%)
PYPL   80.39 (+1.63%)
NFLX   365.01 (-0.80%)
QQQ   292.59 (+1.69%)
AAPL   143.49 (+1.15%)
MSFT   247.06 (+2.68%)
META   147.04 (+3.92%)
GOOGL   97.36 (+2.25%)
AMZN   98.69 (+1.55%)
TSLA   159.50 (+10.43%)
NVDA   196.70 (+1.80%)
NIO   12.13 (+4.30%)
BABA   120.61 (+0.30%)
AMD   74.66 (-0.33%)
T   19.93 (-2.40%)
MU   62.48 (+1.53%)
F   12.90 (+0.86%)
CGC   2.74 (-0.72%)
GE   81.21 (+0.52%)
DIS   109.38 (+1.17%)
AMC   5.24 (-1.69%)
PFE   44.17 (-2.00%)
PYPL   80.39 (+1.63%)
NFLX   365.01 (-0.80%)
QQQ   292.59 (+1.69%)
AAPL   143.49 (+1.15%)
MSFT   247.06 (+2.68%)
META   147.04 (+3.92%)
GOOGL   97.36 (+2.25%)
AMZN   98.69 (+1.55%)
TSLA   159.50 (+10.43%)
NVDA   196.70 (+1.80%)
NIO   12.13 (+4.30%)
BABA   120.61 (+0.30%)
AMD   74.66 (-0.33%)
T   19.93 (-2.40%)
MU   62.48 (+1.53%)
F   12.90 (+0.86%)
CGC   2.74 (-0.72%)
GE   81.21 (+0.52%)
DIS   109.38 (+1.17%)
AMC   5.24 (-1.69%)
PFE   44.17 (-2.00%)
PYPL   80.39 (+1.63%)
NFLX   365.01 (-0.80%)
NYSE:CC

Chemours - CC Stock Forecast, Price & News

$34.95
+0.90 (+2.64%)
(As of 01/26/2023 04:01 PM ET)
Add
Compare
Today's Range
$33.65
$35.00
50-Day Range
$29.54
$34.46
52-Week Range
$22.56
$44.95
Volume
463,043 shs
Average Volume
791,361 shs
Market Capitalization
$5.27 billion
P/E Ratio
6.23
Dividend Yield
2.94%
Price Target
$34.10

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.18 Rating Score
Upside/​Downside
1.2% Downside
$34.10 Price Target
Short Interest
Healthy
2.60% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.49mentions of Chemours in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-7.07%
From $4.67 to $4.34 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Basic Materials Sector

56th out of 162 stocks

Chemicals & Allied Products Industry

5th out of 15 stocks


CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

Investors Find Booming Stocks
The bear market could see a bull run in a little-known sector with a $369B infusion.
Chemours (NYSE:CC) Sees Large Volume Increase
Chemours (NYSE:CC) Raised to "Buy" at UBS Group
Reviewing Chemours (NYSE:CC) & Standard Lithium (OTCMKTS:SLI)
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
Chemours director resigns over 'woke culture'
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Last Earnings
11/04/2021
Ex-Dividend for 12/15 Dividend
11/14/2022
Dividend Payable
12/15/2022
Today
1/26/2023
Next Earnings (Confirmed)
2/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$34.10
High Stock Price Forecast
$43.00
Low Stock Price Forecast
$24.00
Forecasted Upside/Downside
-2.4%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

Net Income
$608 million
Pretax Margin
15.79%

Debt

Sales & Book Value

Annual Sales
$6.35 billion
Cash Flow
$6.22 per share
Book Value
$6.64 per share

Miscellaneous

Free Float
146,330,000
Market Cap
$5.27 billion
Optionable
Optionable
Beta
1.84

Key Executives

  • Mark E. NewmanMark E. Newman
    President, Chief Executive Officer & Director
  • Sameer RalhanSameer Ralhan
    Chief Financial Officer & Senior Vice President
  • Kristine Wellman
    Secretary, Senior Vice President & General Counsel
  • Camela T. Wisel
    Chief Accounting Officer, VP & Controller
  • Alisha BellezzaAlisha Bellezza
    President-Thermal & Specialized Solutions













CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price forecast for 2023?

11 brokers have issued 12 month target prices for Chemours' stock. Their CC share price forecasts range from $24.00 to $43.00. On average, they predict the company's stock price to reach $34.10 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2023?

Chemours' stock was trading at $30.62 at the start of the year. Since then, CC stock has increased by 11.2% and is now trading at $34.05.
View the best growth stocks for 2023 here
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our CC earnings forecast
.

How can I listen to Chemours' earnings call?

Chemours will be holding an earnings conference call on Friday, February 10th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) issued its quarterly earnings data on Thursday, November, 4th. The specialty chemicals company reported $1.27 EPS for the quarter, beating the consensus estimate of $0.99 by $0.28. The specialty chemicals company earned $1.68 billion during the quarter, compared to analyst estimates of $1.58 billion. Chemours had a trailing twelve-month return on equity of 73.45% and a net margin of 12.91%. The business's revenue was up 36.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.47 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Tuesday, October 25th. Stockholders of record on Tuesday, November 15th will be paid a dividend of $0.25 per share on Thursday, December 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.94%. The ex-dividend date is Monday, November 14th.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 2.90%. The dividend payout ratio is 17.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 23.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CC.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by many different retail and institutional investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.14%), Assenagon Asset Management S.A. (0.08%), Yousif Capital Management LLC (0.05%), Louisiana State Employees Retirement System (0.03%), Bourgeon Capital Management LLC (0.02%) and Crossmark Global Holdings Inc. (0.02%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, E Bryan Snell, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Richard H Brown and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $34.05.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $5.14 billion and generates $6.35 billion in revenue each year. The specialty chemicals company earns $608 million in net income (profit) each year or $5.61 on an earnings per share basis.

How many employees does Chemours have?

The company employs 6,400 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 1/26/2023 by MarketBeat.com Staff